TET2 binds the androgen receptor and loss is associated with prostate cancer

Genetic alterations associated with prostate cancer (PCa) may be identified by sequencing metastatic tumor genomes to identify molecular markers at this lethal stage of disease. Previously, we characterized somatic alterations in metastatic tumors in the methylcytosine dioxygenase ten-eleven translo...

Descripción completa

Detalles Bibliográficos
Autores principales: Nickerson, ML, Das, S, Im, KM, Turan, S, Berndt, SI, Li, H, Lou, H, Brodie, SA, Billaud, JN, Zhang, T, Bouk, AJ, Butcher, D, Wang, Z, Sun, L, Misner, K, Tan, W, Esnakula, A, Esposito, D, Huang, WY, Hoover, RN, Tucker, MA, Keller, JR, Boland, J, Brown, K, Anderson, SK, Moore, LE, Isaacs, WB, Chanock, SJ, Yeager, M, Dean, M, Andresson, T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5391277/
https://www.ncbi.nlm.nih.gov/pubmed/27819678
http://dx.doi.org/10.1038/onc.2016.376

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5391277/
https://www.ncbi.nlm.nih.gov/pubmed/27819678
http://dx.doi.org/10.1038/onc.2016.376

Ejemplares similares